Prof. Dr. Norbert Heimburger, a CSL Behring employee for over three decades, devoted his work to blood coagulation. During that time, he characterized and purified a large number of plasma proteins and was instrumental in making these available to the medical community as therapeutic options. One of his major contributions in this area was the development of virus-safe plasma products based on pasteurization (heating in solution to 60°C for 10 hours).
Due to his determination and constant interaction with leading hemophilia and coagulation specialists, Behring launched the first effectively virus-inactivated factor VIII concentrate in 1981. In 1991, Prof. Dr. Heimburger was honored with the Order of Merit of the Federal Republic of Germany. He retired the same year but was still very much involved with CSL Behring as a Scientific Advisor until his death in September 2006.
Due to his determination and constant interaction with leading hemophilia and coagulation specialists, Behring launched the first effectively virus-inactivated factor VIII concentrate in 1981. In 1991, Prof. Dr. Heimburger was honored with the Order of Merit of the Federal Republic of Germany. He retired the same year but was still very much involved with CSL Behring as a Scientific Advisor until his death in September 2006.
CSL Behring now awards a grant — the CSL Behring Professor Heimburger Award — to investigators relatively new to the field of coagulation, who hold an MD and who wish to establish their own independent research project in the field of coagulation.
Download the online application form for the CSL Behring - Professor Heimburger Award. View the Professor Heimburger Award Newsletter in Thrombosis & Haemostasis.
Last Updated:
9/9/2011 1:37 PM